These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 30779440
1. Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers Protocol. Sinha J, Mehta N, Dodge JL, Poltavskiy E, Roberts J, Yao F. Hepatology; 2019 Oct; 70(4):1185-1196. PubMed ID: 30779440 [Abstract] [Full Text] [Related]
2. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria. Degroote H, Piñero F, Costentin C, Notarpaolo A, Boin IF, Boudjema K, Baccaro C, Chagas AL, Bachellier P, Ettorre GM, Poniachik J, Muscari F, Di Benedetto F, Duque SH, Salame E, Cillo U, Gadano A, Vanlemmens C, Fagiuoli S, Rubinstein F, Burra P, Cherqui D, Silva M, Van Vlierberghe H, Duvoux C, French-Italian-Belgium and Latin American collaborative group for HCC and liver transplantation. JHEP Rep; 2021 Oct; 3(5):100331. PubMed ID: 34485882 [Abstract] [Full Text] [Related]
3. National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time. Mehta N, Dodge JL, Grab JD, Yao FY. Hepatology; 2020 Mar; 71(3):943-954. PubMed ID: 31344273 [Abstract] [Full Text] [Related]
4. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging. Affonso BB, Galastri FL, da Motta Leal Filho JM, Nasser F, Falsarella PM, Cavalcante RN, de Almeida MD, Felga GEG, Valle LGM, Wolosker N. World J Gastroenterol; 2019 Oct 07; 25(37):5687-5701. PubMed ID: 31602168 [Abstract] [Full Text] [Related]
11. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Finn RS, Tong M, Hiatt JR, Busuttil RW. J Am Coll Surg; 2015 Apr 07; 220(4):416-27. PubMed ID: 25690672 [Abstract] [Full Text] [Related]
12. Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience. Victor DW, Monsour HP, Boktour M, Lunsford K, Balogh J, Graviss EA, Nguyen DT, McFadden R, Divatia MK, Heyne K, Ankoma-Sey V, Egwim C, Galati J, Duchini A, Saharia A, Mobley C, Gaber AO, Ghobrial RM. Transplantation; 2020 Jan 07; 104(1):113-121. PubMed ID: 31233480 [Abstract] [Full Text] [Related]
13. National Experience on Waitlist Outcomes for Down-Staging of Hepatocellular Carcinoma: High Dropout Rate in All-Comers. Huang AC, Dodge JL, Yao FY, Mehta N. Clin Gastroenterol Hepatol; 2023 Jun 07; 21(6):1581-1589. PubMed ID: 36038129 [Abstract] [Full Text] [Related]
18. Effect of Downstaging and Bridging of Hepatocellular Carcinoma on Survival Following Liver Transplant: A Single Center Experience. Al Sebayel MI, Elsiesy H, Al-Hamoudi W, Alabbad S, ElSheikh Y, Elbeshbeshy H, Salih I, Yousif S, Saleh Y, Eldali A, Abaalkhail FA. Exp Clin Transplant; 2017 Mar 07; 15(Suppl 2):7-11. PubMed ID: 28301992 [Abstract] [Full Text] [Related]